CoChat

Chromium picolinate for reducing body weight: Meta-analysis of randomized trials

Pittler, M H, Stevinson, C, Ernst, E · 2003 · International Journal of Obesity

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.

Abstract

The aim of this meta-analysis was to assess the evidence of chromium picolinate for reducing body weight. Literature searches were conducted on Medline, Embase, The Cochrane Library, Amed and Ciscom. Nine experts and four manufacturers of commercial preparations containing chromium picolinate were asked to contribute published and unpublished studies. There were no restrictions regarding the language of publication. The screening of studies, selection, data extraction, validation and the assessment of methodological quality were performed independently by two reviewers. To be included, studies were required to state that they were randomized, double-blind and placebo-controlled, and report on body weight. Ten trials met all inclusion criteria and provided data, which were suitable for statistical pooling. For body weight a significant differential effect was found in favour of chromium picolinate (weighted mean difference: -1.1 kg; 95% confidence interval (CI): -1.8 to -0.4 kg, n=489). Sensitivity analysis suggests that this effect is largely dependent on the results of a single trial (weighted mean difference: -0.9 kg; 95% CI: -2.0 to 0.2 kg, n=335). Three of the reviewed trials reported on adverse events, indicating their absence in the treatment groups. In conclusion, our meta-analysis suggests a relatively small effect of chromium picolinate compared with placebo for reducing body weight. The clinical relevance of the effect is debatable and the lack of robustness means that the result has to be interpreted with caution.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.ijo.0802262

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 69 references

Research works printed but not linked: 4

  1. Trent LK, Thieding-Cancel D . Effect of chromium picolinate on body composition. J Sports Med Phys Fitness 1995; 35: 273–280.
  2. Ravina A, Slezak L, Rubal A, Mirsky N . Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elements Exp Med 1995; 8: 183–190.
  3. Bahadori B, Wallner S, Schneider H, Wascher TC, Toplak H . Effekt von Chromhefe und Chrompicolinat auf die Körperzusammensetzung bei übergewichtigen, nichtdiabetischen Patienten während und nach einer Formula-Diät. Acta Med Aust 1997; 24: 185–187.
  4. Evans GW . The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosocial Med Res 1989; 11: 163–180.

Cited by

See all 131

Metadata

Authors
Pittler, M. H., Stevinson, C., & Ernst, E.
Affiliations
  • University of Exeter (GB)
  • University of Bristol (GB)
Corresponding author
Pittler, M H
Venue
International Journal of Obesity
Published
2003-03-27
Volume
27
Issue
4
Pages
522-529
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W2132322696
Cited by
131
References
70
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 6
FWCI
1.26
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • International Journal of Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Chromium effects and bioremediation
Keywords
chromium picolinate, weight loss, dietary supplements, obesity, placebo effect, adverse events
MeSH terms
Female, Humans, Iron Chelating Agents, Male, Obesity, Picolinic Acids, Randomized Controlled Trials as Topic, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.